"","title","geo_accession","status","submission_date","last_update_date","type","channel_count","source_name_ch1","organism_ch1","characteristics_ch1","characteristics_ch1.1","characteristics_ch1.2","characteristics_ch1.3","characteristics_ch1.4","characteristics_ch1.5","characteristics_ch1.6","characteristics_ch1.7","molecule_ch1","extract_protocol_ch1","label_ch1","label_protocol_ch1","taxid_ch1","source_name_ch2","organism_ch2","characteristics_ch2","molecule_ch2","extract_protocol_ch2","label_ch2","label_protocol_ch2","taxid_ch2","hyb_protocol","scan_protocol","description","description.1","data_processing","platform_id","contact_name","contact_email","contact_laboratory","contact_department","contact_institute","contact_address","contact_city","contact_zip/postal_code","contact_country","supplementary_file","data_row_count"
"GSM497878","N_003_Hv3_35k_h1","GSM497878","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor N_003","Homo sapiens","sample histology: Normal bladder","","","","","","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Samples were dissolved in 42 microliter Universal Hybridization Solution (Corning) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed using the Pronto Plus System (Promega)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","N_003_ureter_Hv3_35k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL5186","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497878/GSM497878.gpr.gz","20866"
"GSM497879","N_005_Hv3_35k_h1","GSM497879","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor N_005","Homo sapiens","sample histology: Normal bladder","","","","","","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Samples were dissolved in 42 microliter Universal Hybridization Solution (Corning) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed using the Pronto Plus System (Promega)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","N_005_ureter_Hv3_35k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL5186","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497879/GSM497879.gpr.gz","20866"
"GSM497880","N_006_Hv3_35k_h1","GSM497880","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor N_006","Homo sapiens","sample histology: Normal bladder","","","","","","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Samples were dissolved in 42 microliter Universal Hybridization Solution (Corning) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed using the Pronto Plus System (Promega)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","N_006_ureter_Hv3_35k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL5186","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497880/GSM497880.gpr.gz","20866"
"GSM497881","N_007_Hv3_35k_h1","GSM497881","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor N_007","Homo sapiens","sample histology: Normal bladder","","","","","","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Samples were dissolved in 42 microliter Universal Hybridization Solution (Corning) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed using the Pronto Plus System (Promega)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","N_007_ureter_Hv3_35k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL5186","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497881/GSM497881.gpr.gz","20866"
"GSM497882","N_008_Hv3_35k_h1","GSM497882","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor N_008","Homo sapiens","sample histology: Normal bladder","","","","","","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Samples were dissolved in 42 microliter Universal Hybridization Solution (Corning) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed using the Pronto Plus System (Promega)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","N_008_ureter_Hv3_35k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL5186","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497882/GSM497882.gpr.gz","20866"
"GSM497883","N_009_Hv3_35k_h1","GSM497883","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor N_009","Homo sapiens","sample histology: Normal bladder","","","","","","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Samples were dissolved in 42 microliter Universal Hybridization Solution (Corning) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed using the Pronto Plus System (Promega)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","N_009_Urothel_Hv3_35k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL5186","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497883/GSM497883.gpr.gz","20866"
"GSM497884","N_013_Hv3_35k_h1","GSM497884","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor N_013","Homo sapiens","sample histology: Normal bladder","","","","","","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Samples were dissolved in 42 microliter Universal Hybridization Solution (Corning) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed using the Pronto Plus System (Promega)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","N_013_Urothel_Hv3_35k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL5186","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497884/GSM497884.gpr.gz","20866"
"GSM497885","UC_0001_1_Hv3_35k_h1","GSM497885","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0001_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: T3","tumor grade: G3","dead of disease: NO","follow up time (months): 76.7","cystectomy: YES","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Samples were dissolved in 42 microliter Universal Hybridization Solution (Corning) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed using the Pronto Plus System (Promega)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0001_1_Hv3_35k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL5186","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497885/GSM497885.gpr.gz","20866"
"GSM497886","UC_0002_1_Hv3_35k_h2","GSM497886","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0002_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: T2","tumor grade: G2","dead of disease: YES","follow up time (months): 1.2","","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Samples were dissolved in 42 microliter Universal Hybridization Solution (Corning) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed using the Pronto Plus System (Promega)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0002_1_Hv3_35k_h2","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL5186","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497886/GSM497886.gpr.gz","20866"
"GSM497887","UC_0003_1_Hv3_35k_h1","GSM497887","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0003_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: T1","tumor grade: G2","dead of disease: NO","follow up time (months): 69.9","tat1 progress^to minv/cystectomy/dead: YES^cystectomy","cystectomy: YES","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Samples were dissolved in 42 microliter Universal Hybridization Solution (Corning) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed using the Pronto Plus System (Promega)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0003_1_Hv3_35k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL5186","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497887/GSM497887.gpr.gz","20866"
"GSM497888","UC_0007_1_Hv3_35k_h1","GSM497888","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0007_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: T3","tumor grade: G3","dead of disease: YES","follow up time (months): 36.4","cystectomy: YES","distant metastasis: M+","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Samples were dissolved in 42 microliter Universal Hybridization Solution (Corning) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed using the Pronto Plus System (Promega)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0007_1_Hv3_35k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL5186","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497888/GSM497888.gpr.gz","20866"
"GSM497889","UC_0009_1_Hv3_35k_h1","GSM497889","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0009_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: Ta","tumor grade: G2","dead of disease: NO","follow up time (months): 63.9","tat1 progress^to minv/cystectomy/dead: NO","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Samples were dissolved in 42 microliter Universal Hybridization Solution (Corning) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed using the Pronto Plus System (Promega)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0009_1_Hv3_35k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL5186","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497889/GSM497889.gpr.gz","20866"
"GSM497890","UC_0010_1_Hv3_35k_h1","GSM497890","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0010_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: T1","tumor grade: G2","dead of disease: NO","follow up time (months): 42.5","tat1 progress^to minv/cystectomy/dead: NO","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Samples were dissolved in 42 microliter Universal Hybridization Solution (Corning) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed using the Pronto Plus System (Promega)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0010_1_Hv3_35k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL5186","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497890/GSM497890.gpr.gz","20866"
"GSM497891","UC_0016_1_Hv3_35k_h1","GSM497891","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0016_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: T3","tumor grade: G3","dead of disease: YES","follow up time (months): 5.4","cystectomy: YES","distant metastasis: M+","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Samples were dissolved in 42 microliter Universal Hybridization Solution (Corning) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed using the Pronto Plus System (Promega)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0016_1_Hv3_35k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL5186","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497891/GSM497891.gpr.gz","20866"
"GSM497892","UC_0022_1_Hv3_35k_h1","GSM497892","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0022_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: T4","tumor grade: G3","dead of disease: YES","follow up time (months): 11.2","cystectomy: YES","distant metastasis: M+","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Samples were dissolved in 42 microliter Universal Hybridization Solution (Corning) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed using the Pronto Plus System (Promega)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0022_1_Hv3_35k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL5186","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497892/GSM497892.gpr.gz","20866"
"GSM497893","UC_0023_1_Hv3_35k_h1","GSM497893","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0023_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: T3","tumor grade: G3","dead of disease: NO","follow up time (months): 75.9","cystectomy: YES","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Samples were dissolved in 42 microliter Universal Hybridization Solution (Corning) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed using the Pronto Plus System (Promega)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0023_1_Hv3_35k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL5186","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497893/GSM497893.gpr.gz","20866"
"GSM497894","UC_0034_1_Hv3_35k_h1","GSM497894","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0034_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: T3","tumor grade: G3","dead of disease: NO","follow up time (months): 25.5","cystectomy: YES","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Samples were dissolved in 42 microliter Universal Hybridization Solution (Corning) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed using the Pronto Plus System (Promega)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0034_1_Hv3_35k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL5186","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497894/GSM497894.gpr.gz","20866"
"GSM497895","UC_0035_1_Hv3_35k_h1","GSM497895","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0035_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: Tx","tumor grade: Gx","","","","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Samples were dissolved in 42 microliter Universal Hybridization Solution (Corning) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed using the Pronto Plus System (Promega)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0035_1_Hv3_35k_h1","This is one of two samples that were hybridized to both 27k and 35k platforms. They were only used for merging of the two expression datasets.","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL5186","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497895/GSM497895.gpr.gz","20866"
"GSM497896","UC_0039_1_Hv3_35k_h1","GSM497896","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0039_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: T2^Nested","tumor grade: G3^Nested","dead of disease: YES","follow up time (months): 1.8","","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Samples were dissolved in 42 microliter Universal Hybridization Solution (Corning) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed using the Pronto Plus System (Promega)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0039_1_Hv3_35k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL5186","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497896/GSM497896.gpr.gz","20866"
"GSM497897","UC_0040_1_Hv3_35k_h1","GSM497897","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0040_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: T1","tumor grade: G3","dead of disease: NO","follow up time (months): 1.2","tat1 progress^to minv/cystectomy/dead: NO","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Samples were dissolved in 42 microliter Universal Hybridization Solution (Corning) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed using the Pronto Plus System (Promega)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0040_1_Hv3_35k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL5186","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497897/GSM497897.gpr.gz","20866"
"GSM497898","UC_0042_1_Hv3_35k_h1","GSM497898","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0042_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: Ta","tumor grade: G2","dead of disease: NO","follow up time (months): 68.8","tat1 progress^to minv/cystectomy/dead: NO","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Samples were dissolved in 42 microliter Universal Hybridization Solution (Corning) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed using the Pronto Plus System (Promega)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0042_1_Hv3_35k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL5186","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497898/GSM497898.gpr.gz","20866"
"GSM497899","UC_0046_1_Hv3_35k_h1","GSM497899","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0046_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: T4","tumor grade: G3","dead of disease: YES","follow up time (months): 6.0","cystectomy: YES","distant metastasis: M+","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Samples were dissolved in 42 microliter Universal Hybridization Solution (Corning) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed using the Pronto Plus System (Promega)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0046_1_Hv3_35k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL5186","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497899/GSM497899.gpr.gz","20866"
"GSM497900","UC_0053_1_Hv3_35k_h1","GSM497900","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0053_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: T1","tumor grade: G3","dead of disease: NO","follow up time (months): 66.1","tat1 progress^to minv/cystectomy/dead: YES^cystectomy+met","cystectomy: YES","distant metastasis: M+","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Samples were dissolved in 42 microliter Universal Hybridization Solution (Corning) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed using the Pronto Plus System (Promega)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0053_1_Hv3_35k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL5186","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497900/GSM497900.gpr.gz","20866"
"GSM497901","UC_0057_1_Hv3_35k_h1","GSM497901","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0057_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: Ta","tumor grade: G3","dead of disease: NO","follow up time (months): 62.6","tat1 progress^to minv/cystectomy/dead: NO","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Samples were dissolved in 42 microliter Universal Hybridization Solution (Corning) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed using the Pronto Plus System (Promega)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0057_1_Hv3_35k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL5186","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497901/GSM497901.gpr.gz","20866"
"GSM497902","UC_0059_1_Hv3_35k_h1","GSM497902","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0059_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: T2","tumor grade: G3","dead of disease: NO","follow up time (months): 64.8","","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Samples were dissolved in 42 microliter Universal Hybridization Solution (Corning) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed using the Pronto Plus System (Promega)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0059_1_Hv3_35k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL5186","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497902/GSM497902.gpr.gz","20866"
"GSM497903","UC_0060_1_Hv3_35k_h1","GSM497903","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0060_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: Ta","tumor grade: G2","dead of disease: YES","follow up time (months): 32.3","tat1 progress^to minv/cystectomy/dead: YES","cystectomy: YES","distant metastasis: M+","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Samples were dissolved in 42 microliter Universal Hybridization Solution (Corning) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed using the Pronto Plus System (Promega)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0060_1_Hv3_35k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL5186","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497903/GSM497903.gpr.gz","20866"
"GSM497904","UC_0067_1_Hv3_35k_h1","GSM497904","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0067_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: T1","tumor grade: G2","dead of disease: NO","follow up time (months): 66.7","tat1 progress^to minv/cystectomy/dead: NO","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Samples were dissolved in 42 microliter Universal Hybridization Solution (Corning) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed using the Pronto Plus System (Promega)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0067_1_Hv3_35k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL5186","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497904/GSM497904.gpr.gz","20866"
"GSM497905","UC_0069_1_Hv3_35k_h1","GSM497905","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0069_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: T3","tumor grade: G3","dead of disease: NO","follow up time (months): 66.6","cystectomy: YES","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Samples were dissolved in 42 microliter Universal Hybridization Solution (Corning) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed using the Pronto Plus System (Promega)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0069_1_Hv3_35k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL5186","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497905/GSM497905.gpr.gz","20866"
"GSM497906","UC_0073_1_Hv3_35k_h1","GSM497906","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0073_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: Ta","tumor grade: G3","dead of disease: NO","follow up time (months): 28.5","tat1 progress^to minv/cystectomy/dead: NO","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Samples were dissolved in 42 microliter Universal Hybridization Solution (Corning) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed using the Pronto Plus System (Promega)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0073_1_Hv3_35k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL5186","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497906/GSM497906.gpr.gz","20866"
"GSM497907","UC_0077_1_Hv3_35k_h1","GSM497907","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0077_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: T1","tumor grade: G3","dead of disease: YES","follow up time (months): 32.9","tat1 progress^to minv/cystectomy/dead: YES","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Samples were dissolved in 42 microliter Universal Hybridization Solution (Corning) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed using the Pronto Plus System (Promega)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0077_1_Hv3_35k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL5186","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497907/GSM497907.gpr.gz","20866"
"GSM497908","UC_0086_1_Hv3_35k_h1","GSM497908","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0086_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: T2","tumor grade: G3","dead of disease: NO","follow up time (months): 54.9","cystectomy: YES","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Samples were dissolved in 42 microliter Universal Hybridization Solution (Corning) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed using the Pronto Plus System (Promega)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0086_1_Hv3_35k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL5186","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497908/GSM497908.gpr.gz","20866"
"GSM497909","UC_0089_1_Hv3_35k_h1","GSM497909","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0089_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: Ta","tumor grade: G2","dead of disease: NO","follow up time (months): 40.1","tat1 progress^to minv/cystectomy/dead: NO","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Samples were dissolved in 42 microliter Universal Hybridization Solution (Corning) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed using the Pronto Plus System (Promega)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0089_1_Hv3_35k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL5186","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497909/GSM497909.gpr.gz","20866"
"GSM497910","UC_0093_1_Hv3_35k_h1","GSM497910","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0093_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: T3","tumor grade: G3","dead of disease: YES","follow up time (months): 26.5","cystectomy: YES","distant metastasis: M+","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Samples were dissolved in 42 microliter Universal Hybridization Solution (Corning) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed using the Pronto Plus System (Promega)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0093_1_Hv3_35k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL5186","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497910/GSM497910.gpr.gz","20866"
"GSM497911","UC_0095_1_Hv3_35k_h1","GSM497911","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0095_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: T3","tumor grade: G3","dead of disease: YES","follow up time (months): 29.4","cystectomy: YES","distant metastasis: M+","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Samples were dissolved in 42 microliter Universal Hybridization Solution (Corning) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed using the Pronto Plus System (Promega)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0095_1_Hv3_35k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL5186","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497911/GSM497911.gpr.gz","20866"
"GSM497912","UC_0097_1_Hv3_35k_h1","GSM497912","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0097_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: Ta","tumor grade: G3","dead of disease: NO","follow up time (months): 38.4","tat1 progress^to minv/cystectomy/dead: NO","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Samples were dissolved in 42 microliter Universal Hybridization Solution (Corning) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed using the Pronto Plus System (Promega)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0097_1_Hv3_35k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL5186","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497912/GSM497912.gpr.gz","20866"
"GSM497913","UC_0101_1_Hv3_35k_h1","GSM497913","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0101_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: T1","tumor grade: G2","dead of disease: NO","follow up time (months): 27.8","tat1 progress^to minv/cystectomy/dead: NO","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Samples were dissolved in 42 microliter Universal Hybridization Solution (Corning) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed using the Pronto Plus System (Promega)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0101_1_Hv3_35k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL5186","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497913/GSM497913.gpr.gz","20866"
"GSM497914","UC_0102_2_Hv3_35k_h1","GSM497914","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0102_2","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: T2","tumor grade: G3","dead of disease: NO","follow up time (months): 27.9","","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Samples were dissolved in 42 microliter Universal Hybridization Solution (Corning) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed using the Pronto Plus System (Promega)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0102_2_Hv3_35k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL5186","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497914/GSM497914.gpr.gz","20866"
"GSM497915","UC_0109_1_Hv3_35k_h1","GSM497915","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0109_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: T2^Nested","tumor grade: G3^Nested","dead of disease: NO","follow up time (months): 58.9","cystectomy: YES","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Samples were dissolved in 42 microliter Universal Hybridization Solution (Corning) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed using the Pronto Plus System (Promega)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0109_1_Hv3_35k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL5186","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497915/GSM497915.gpr.gz","20866"
"GSM497916","UC_0111_1_Hv3_35k_h1","GSM497916","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0111_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: T1","tumor grade: G2","dead of disease: YES","follow up time (months): 10.3","tat1 progress^to minv/cystectomy/dead: YES","distant metastasis: M+","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Samples were dissolved in 42 microliter Universal Hybridization Solution (Corning) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed using the Pronto Plus System (Promega)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0111_1_Hv3_35k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL5186","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497916/GSM497916.gpr.gz","20866"
"GSM497917","UC_0117_1_Hv3_35k_h1","GSM497917","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0117_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: T2","tumor grade: G3","dead of disease: YES","follow up time (months): 0.1","","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Samples were dissolved in 42 microliter Universal Hybridization Solution (Corning) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed using the Pronto Plus System (Promega)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0117_1_Hv3_35k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL5186","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497917/GSM497917.gpr.gz","20866"
"GSM497918","UC_0120_1_Hv3_35k_h1","GSM497918","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0120_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: T1","tumor grade: G3","dead of disease: NO","follow up time (months): 42.8","tat1 progress^to minv/cystectomy/dead: NO","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Samples were dissolved in 42 microliter Universal Hybridization Solution (Corning) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed using the Pronto Plus System (Promega)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0120_1_Hv3_35k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL5186","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497918/GSM497918.gpr.gz","20866"
"GSM497919","UC_0122_1_Hv3_35k_h1","GSM497919","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0122_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: T1","tumor grade: G3","dead of disease: NO","follow up time (months): 59.7","tat1 progress^to minv/cystectomy/dead: NO","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Samples were dissolved in 42 microliter Universal Hybridization Solution (Corning) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed using the Pronto Plus System (Promega)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0122_1_Hv3_35k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL5186","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497919/GSM497919.gpr.gz","20866"
"GSM497920","UC_0134_1_Hv3_35k_h1","GSM497920","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0134_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: T2","tumor grade: G3","dead of disease: NO","follow up time (months): 51.5","cystectomy: YES","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Samples were dissolved in 42 microliter Universal Hybridization Solution (Corning) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed using the Pronto Plus System (Promega)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0134_1_Hv3_35k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL5186","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497920/GSM497920.gpr.gz","20866"
"GSM497921","UC_0138_1_Hv3_35k_h1","GSM497921","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0138_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: T2","tumor grade: G3","dead of disease: NO","follow up time (months): 54.4","cystectomy: YES","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Samples were dissolved in 42 microliter Universal Hybridization Solution (Corning) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed using the Pronto Plus System (Promega)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0138_1_Hv3_35k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL5186","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497921/GSM497921.gpr.gz","20866"
"GSM497922","UC_0139_2_Hv3_35k_h1","GSM497922","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0139_2","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: T2","tumor grade: G3","dead of disease: YES","follow up time (months): 5.0","","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Samples were dissolved in 42 microliter Universal Hybridization Solution (Corning) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed using the Pronto Plus System (Promega)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0139_2_Hv3_35k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL5186","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497922/GSM497922.gpr.gz","20866"
"GSM497923","UC_0152_1_Hv3_35k_h1","GSM497923","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0152_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: T1","tumor grade: G3","dead of disease: NO","follow up time (months): 27.3","tat1 progress^to minv/cystectomy/dead: NO","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Samples were dissolved in 42 microliter Universal Hybridization Solution (Corning) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed using the Pronto Plus System (Promega)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0152_1_Hv3_35k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL5186","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497923/GSM497923.gpr.gz","20866"
"GSM497924","UC_0154_1_Hv3_35k_h1","GSM497924","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0154_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: T1","tumor grade: G3","dead of disease: YES","follow up time (months): 36.6","tat1 progress^to minv/cystectomy/dead: YES","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Samples were dissolved in 42 microliter Universal Hybridization Solution (Corning) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed using the Pronto Plus System (Promega)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0154_1_Hv3_35k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL5186","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497924/GSM497924.gpr.gz","20866"
"GSM497925","UC_0159_1_Hv3_35k_h1","GSM497925","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0159_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: T1","tumor grade: G2","dead of disease: NO","follow up time (months): 51.0","tat1 progress^to minv/cystectomy/dead: NO","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Samples were dissolved in 42 microliter Universal Hybridization Solution (Corning) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed using the Pronto Plus System (Promega)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0159_1_Hv3_35k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL5186","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497925/GSM497925.gpr.gz","20866"
"GSM497926","UC_0166_1_Hv3_35k_h1","GSM497926","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0166_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: T2","tumor grade: G3","dead of disease: NO","follow up time (months): 49.8","cystectomy: YES","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Samples were dissolved in 42 microliter Universal Hybridization Solution (Corning) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed using the Pronto Plus System (Promega)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0166_1_Hv3_35k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL5186","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497926/GSM497926.gpr.gz","20866"
"GSM497927","UC_0169_1_Hv3_35k_h1","GSM497927","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0169_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: T3","tumor grade: G3","dead of disease: NO","follow up time (months): 49.6","cystectomy: YES","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Samples were dissolved in 42 microliter Universal Hybridization Solution (Corning) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed using the Pronto Plus System (Promega)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0169_1_Hv3_35k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL5186","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497927/GSM497927.gpr.gz","20866"
"GSM497928","UC_0170_1_Hv3_35k_h1","GSM497928","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0170_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: T1","tumor grade: G3","dead of disease: NO","follow up time (months): 48.6","tat1 progress^to minv/cystectomy/dead: NO","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Samples were dissolved in 42 microliter Universal Hybridization Solution (Corning) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed using the Pronto Plus System (Promega)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0170_1_Hv3_35k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL5186","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497928/GSM497928.gpr.gz","20866"
"GSM497929","UC_0179_1_Hv3_35k_h1","GSM497929","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0179_1","Homo sapiens","sample histology: Upper urinary tract urothelial carcinoma","tumor stage: Ta","tumor grade: G3","","","","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Samples were dissolved in 42 microliter Universal Hybridization Solution (Corning) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed using the Pronto Plus System (Promega)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0179_1_Hv3_35k_h1","This is one of two samples that were hybridized to both 27k and 35k platforms. They were only used for merging of the two expression datasets.","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL5186","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497929/GSM497929.gpr.gz","20866"
"GSM497930","UC_0184_1_Hv3_35k_h1","GSM497930","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0184_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: Ta","tumor grade: G2","dead of disease: NO","follow up time (months): 45.1","tat1 progress^to minv/cystectomy/dead: YES^cystectomy","cystectomy: YES","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Samples were dissolved in 42 microliter Universal Hybridization Solution (Corning) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed using the Pronto Plus System (Promega)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0184_1_Hv3_35k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL5186","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497930/GSM497930.gpr.gz","20866"
"GSM497931","UC_0185_1_Hv3_35k_h2","GSM497931","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0185_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: T1","tumor grade: G2","dead of disease: NO","follow up time (months): 49.7","tat1 progress^to minv/cystectomy/dead: NO","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Samples were dissolved in 42 microliter Universal Hybridization Solution (Corning) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed using the Pronto Plus System (Promega)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0185_1_Hv3_35k_h2","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL5186","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497931/GSM497931.gpr.gz","20866"
"GSM497932","UC_0187_1_Hv3_35k_h1","GSM497932","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0187_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: T3","tumor grade: G3","dead of disease: NO","follow up time (months): 5.5","cystectomy: YES","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Samples were dissolved in 42 microliter Universal Hybridization Solution (Corning) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed using the Pronto Plus System (Promega)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0187_1_Hv3_35k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL5186","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497932/GSM497932.gpr.gz","20866"
"GSM497933","UC_0195_1_Hv3_35k_h1","GSM497933","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0195_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: T2","tumor grade: G3","dead of disease: NO","follow up time (months): 47.9","cystectomy: YES","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Samples were dissolved in 42 microliter Universal Hybridization Solution (Corning) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed using the Pronto Plus System (Promega)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0195_1_Hv3_35k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL5186","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497933/GSM497933.gpr.gz","20866"
"GSM497934","UC_0196_1_Hv3_35k_h2","GSM497934","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0196_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: T2","tumor grade: G3","dead of disease: YES","follow up time (months): 8.2","","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Samples were dissolved in 42 microliter Universal Hybridization Solution (Corning) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed using the Pronto Plus System (Promega)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0196_1_Hv3_35k_h2","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL5186","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497934/GSM497934.gpr.gz","20866"
"GSM497935","UC_0199_2_Hv3_35k_h2","GSM497935","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0199_2","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: T1","tumor grade: G3","dead of disease: YES","follow up time (months): 25.0","tat1 progress^to minv/cystectomy/dead: YES","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Samples were dissolved in 42 microliter Universal Hybridization Solution (Corning) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed using the Pronto Plus System (Promega)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0199_2_Hv3_35k_h2","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL5186","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497935/GSM497935.gpr.gz","20866"
"GSM497936","UC_0200_1_Hv3_35k_h1","GSM497936","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0200_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: T1","tumor grade: G2","dead of disease: NO","follow up time (months): 12.9","tat1 progress^to minv/cystectomy/dead: NO","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Samples were dissolved in 42 microliter Universal Hybridization Solution (Corning) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed using the Pronto Plus System (Promega)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0200_1_Hv3_35k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL5186","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497936/GSM497936.gpr.gz","20866"
"GSM497937","UC_0203_1_Hv3_35k_h1","GSM497937","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0203_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: T1","tumor grade: G3","dead of disease: NO","follow up time (months): 46.2","tat1 progress^to minv/cystectomy/dead: NO","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Samples were dissolved in 42 microliter Universal Hybridization Solution (Corning) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed using the Pronto Plus System (Promega)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0203_1_Hv3_35k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL5186","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497937/GSM497937.gpr.gz","20866"
"GSM497938","UC_0207_1_Hv3_35k_h1","GSM497938","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0207_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: T3","tumor grade: G3","dead of disease: NO","follow up time (months): 54.0","cystectomy: YES","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Samples were dissolved in 42 microliter Universal Hybridization Solution (Corning) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed using the Pronto Plus System (Promega)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0207_1_Hv3_35k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL5186","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497938/GSM497938.gpr.gz","20866"
"GSM497939","UC_0214_1_Hv3_35k_h1","GSM497939","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0214_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: T3","tumor grade: G3","dead of disease: YES","follow up time (months): 6.2","cystectomy: YES","distant metastasis: M+","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Samples were dissolved in 42 microliter Universal Hybridization Solution (Corning) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed using the Pronto Plus System (Promega)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0214_1_Hv3_35k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL5186","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497939/GSM497939.gpr.gz","20866"
"GSM497940","UC_0215_1_Hv3_35k_h1","GSM497940","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0215_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: T1","tumor grade: G3","dead of disease: NO","follow up time (months): 50.6","tat1 progress^to minv/cystectomy/dead: NO","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Samples were dissolved in 42 microliter Universal Hybridization Solution (Corning) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed using the Pronto Plus System (Promega)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0215_1_Hv3_35k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL5186","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497940/GSM497940.gpr.gz","20866"
"GSM497941","UC_0223_1_Hv3_35k_h1","GSM497941","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0223_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: T1","tumor grade: G3","dead of disease: NO","follow up time (months): 43.2","tat1 progress^to minv/cystectomy/dead: NO","cystectomy: YES","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Samples were dissolved in 42 microliter Universal Hybridization Solution (Corning) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed using the Pronto Plus System (Promega)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0223_1_Hv3_35k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL5186","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497941/GSM497941.gpr.gz","20866"
"GSM497942","UC_0224_1_Hv3_35k_h2","GSM497942","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0224_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: T3","tumor grade: G3","dead of disease: YES","follow up time (months): 7.5","cystectomy: YES","distant metastasis: M+","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Samples were dissolved in 42 microliter Universal Hybridization Solution (Corning) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed using the Pronto Plus System (Promega)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0224_1_Hv3_35k_h2","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL5186","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497942/GSM497942.gpr.gz","20866"
"GSM497943","UC_0226_1_Hv3_35k_h1","GSM497943","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0226_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: T1","tumor grade: G2","dead of disease: NO","follow up time (months): 48.7","tat1 progress^to minv/cystectomy/dead: NO","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Samples were dissolved in 42 microliter Universal Hybridization Solution (Corning) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed using the Pronto Plus System (Promega)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0226_1_Hv3_35k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL5186","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497943/GSM497943.gpr.gz","20866"
"GSM497944","UC_0230_1_Hv3_35k_h1","GSM497944","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0230_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: T1","tumor grade: G3","dead of disease: NO","follow up time (months): 51.7","tat1 progress^to minv/cystectomy/dead: NO","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Samples were dissolved in 42 microliter Universal Hybridization Solution (Corning) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed using the Pronto Plus System (Promega)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0230_1_Hv3_35k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL5186","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497944/GSM497944.gpr.gz","20866"
"GSM497945","UC_0231_1_Hv3_35k_h1","GSM497945","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0231_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: T2","tumor grade: G3","dead of disease: NO","follow up time (months): 50.8","","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Samples were dissolved in 42 microliter Universal Hybridization Solution (Corning) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed using the Pronto Plus System (Promega)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0231_1_Hv3_35k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL5186","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497945/GSM497945.gpr.gz","20866"
"GSM497946","UC_0235_1_Hv3_35k_h1","GSM497946","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0235_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: Ta","tumor grade: G3","dead of disease: NO","follow up time (months): 47.6","tat1 progress^to minv/cystectomy/dead: YES","cystectomy: YES","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Samples were dissolved in 42 microliter Universal Hybridization Solution (Corning) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed using the Pronto Plus System (Promega)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0235_1_Hv3_35k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL5186","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497946/GSM497946.gpr.gz","20866"
"GSM497947","UC_0237_1_Hv3_35k_h1","GSM497947","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0237_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: Tx","tumor grade: G3","dead of disease: YES","follow up time (months): 0.6","","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Samples were dissolved in 42 microliter Universal Hybridization Solution (Corning) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed using the Pronto Plus System (Promega)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0237_1_Hv3_35k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL5186","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497947/GSM497947.gpr.gz","20866"
"GSM497948","UC_0241_1_Hv3_35k_h1","GSM497948","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0241_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: T3^Nested","tumor grade: G3^Nested","dead of disease: NO","follow up time (months): 38.7","cystectomy: YES","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Samples were dissolved in 42 microliter Universal Hybridization Solution (Corning) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed using the Pronto Plus System (Promega)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0241_1_Hv3_35k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL5186","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497948/GSM497948.gpr.gz","20866"
"GSM497949","UC_0242_1_Hv3_35k_h1","GSM497949","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0242_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: T4","tumor grade: G3","dead of disease: YES","follow up time (months): 3.8","cystectomy: YES","distant metastasis: M+","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Samples were dissolved in 42 microliter Universal Hybridization Solution (Corning) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed using the Pronto Plus System (Promega)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0242_1_Hv3_35k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL5186","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497949/GSM497949.gpr.gz","20866"
"GSM497950","UC_0249_1_Hv3_35k_h1","GSM497950","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0249_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: Ta","tumor grade: G3","dead of disease: NO","follow up time (months): 48.2","tat1 progress^to minv/cystectomy/dead: NO","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Samples were dissolved in 42 microliter Universal Hybridization Solution (Corning) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed using the Pronto Plus System (Promega)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0249_1_Hv3_35k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL5186","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497950/GSM497950.gpr.gz","20866"
"GSM497951","UC_0250_1_Hv3_35k_h1","GSM497951","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0250_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: T3","tumor grade: G3","dead of disease: NO","follow up time (months): 48.1","cystectomy: YES","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Samples were dissolved in 42 microliter Universal Hybridization Solution (Corning) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed using the Pronto Plus System (Promega)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0250_1_Hv3_35k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL5186","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497951/GSM497951.gpr.gz","20866"
"GSM497952","UC_0263_1_Hv3_35k_h1","GSM497952","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0263_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: Ta","tumor grade: G2","dead of disease: NO","follow up time (months): 47.8","tat1 progress^to minv/cystectomy/dead: YES","cystectomy: YES","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Samples were dissolved in 42 microliter Universal Hybridization Solution (Corning) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed using the Pronto Plus System (Promega)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0263_1_Hv3_35k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL5186","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497952/GSM497952.gpr.gz","20866"
"GSM497953","UC_0265_1_Hv3_35k_h1","GSM497953","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0265_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: T2","tumor grade: G3","dead of disease: YES","follow up time (months): 11.3","","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Samples were dissolved in 42 microliter Universal Hybridization Solution (Corning) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed using the Pronto Plus System (Promega)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0265_1_Hv3_35k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL5186","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497953/GSM497953.gpr.gz","20866"
"GSM497954","UC_0267_3_Hv3_35k_h1","GSM497954","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0267_3","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: T1","tumor grade: G3","dead of disease: NO","follow up time (months): 39.5","tat1 progress^to minv/cystectomy/dead: NO","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Samples were dissolved in 42 microliter Universal Hybridization Solution (Corning) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed using the Pronto Plus System (Promega)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0267_3_Hv3_35k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL5186","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497954/GSM497954.gpr.gz","20866"
"GSM497955","UC_0283_1_Hv3_35k_h1","GSM497955","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0283_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: T1","tumor grade: G3","dead of disease: NO","follow up time (months): 41.6","tat1 progress^to minv/cystectomy/dead: NO","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Samples were dissolved in 42 microliter Universal Hybridization Solution (Corning) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed using the Pronto Plus System (Promega)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0283_1_Hv3_35k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL5186","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497955/GSM497955.gpr.gz","20866"
"GSM497956","UC_0290_1_Hv3_35k_h1","GSM497956","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0290_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: T1","tumor grade: G2","dead of disease: NO","follow up time (months): 39.4","tat1 progress^to minv/cystectomy/dead: NO","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Samples were dissolved in 42 microliter Universal Hybridization Solution (Corning) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed using the Pronto Plus System (Promega)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0290_1_Hv3_35k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL5186","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497956/GSM497956.gpr.gz","20866"
"GSM497957","UC_0301_1_Hv3_35k_h1","GSM497957","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0301_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: T1","tumor grade: G3","dead of disease: NO","follow up time (months): 36.7","tat1 progress^to minv/cystectomy/dead: NO","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Samples were dissolved in 42 microliter Universal Hybridization Solution (Corning) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed using the Pronto Plus System (Promega)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0301_1_Hv3_35k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL5186","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497957/GSM497957.gpr.gz","20866"
"GSM497958","UC_0302_1_Hv3_35k_h1","GSM497958","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0302_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: T1","tumor grade: G3","dead of disease: NO","follow up time (months): 37.2","tat1 progress^to minv/cystectomy/dead: NO","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Samples were dissolved in 42 microliter Universal Hybridization Solution (Corning) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed using the Pronto Plus System (Promega)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0302_1_Hv3_35k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL5186","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497958/GSM497958.gpr.gz","20866"
"GSM497959","UC_0312_1_Hv3_35k_h1","GSM497959","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0312_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: T1","tumor grade: G2","dead of disease: NO","follow up time (months): 31.8","tat1 progress^to minv/cystectomy/dead: NO","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Samples were dissolved in 42 microliter Universal Hybridization Solution (Corning) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed using the Pronto Plus System (Promega)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0312_1_Hv3_35k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL5186","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497959/GSM497959.gpr.gz","20866"
"GSM497960","UC_0321_1_Hv3_35k_h1","GSM497960","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0321_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: T2","tumor grade: G2","dead of disease: YES","follow up time (months): 20.6","cystectomy: YES","distant metastasis: M+","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Samples were dissolved in 42 microliter Universal Hybridization Solution (Corning) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed using the Pronto Plus System (Promega)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0321_1_Hv3_35k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL5186","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497960/GSM497960.gpr.gz","20866"
"GSM497961","UC_0322_2_Hv3_35k_h1","GSM497961","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0322_2","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: Tx","tumor grade: G3","dead of disease: NO","follow up time (months): 30.5","cystectomy: YES","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Samples were dissolved in 42 microliter Universal Hybridization Solution (Corning) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed using the Pronto Plus System (Promega)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0322_2_Hv3_35k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL5186","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497961/GSM497961.gpr.gz","20866"
"GSM497962","UC_0323_1_Hv3_35k_h1","GSM497962","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0323_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: T2^Nested","tumor grade: G3^Nested","dead of disease: YES","follow up time (months): 1.3","","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Samples were dissolved in 42 microliter Universal Hybridization Solution (Corning) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed using the Pronto Plus System (Promega)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0323_1_Hv3_35k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL5186","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497962/GSM497962.gpr.gz","20866"
"GSM497963","UC_0329_1_Hv3_35k_h1","GSM497963","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0329_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: T3","tumor grade: G3","dead of disease: NO","follow up time (months): 40.6","cystectomy: YES","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Samples were dissolved in 42 microliter Universal Hybridization Solution (Corning) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed using the Pronto Plus System (Promega)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0329_1_Hv3_35k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL5186","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497963/GSM497963.gpr.gz","20866"
"GSM497964","UC_0335_1_Hv3_35k_h1","GSM497964","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0335_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: T3","tumor grade: G3","dead of disease: YES","follow up time (months): 17.6","cystectomy: YES","distant metastasis: M+","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Samples were dissolved in 42 microliter Universal Hybridization Solution (Corning) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed using the Pronto Plus System (Promega)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0335_1_Hv3_35k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL5186","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497964/GSM497964.gpr.gz","20866"
"GSM497965","UC_0339_1_Hv3_35k_h1","GSM497965","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0339_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: T3","tumor grade: G3","dead of disease: YES","follow up time (months): 6.8","cystectomy: YES","distant metastasis: M+","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Samples were dissolved in 42 microliter Universal Hybridization Solution (Corning) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed using the Pronto Plus System (Promega)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0339_1_Hv3_35k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL5186","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497965/GSM497965.gpr.gz","20866"
"GSM497966","UC_0349_2_Hv3_35k_h1","GSM497966","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0349_2","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: T1","tumor grade: G3","dead of disease: NO","follow up time (months): 33.2","tat1 progress^to minv/cystectomy/dead: YES","cystectomy: YES","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Samples were dissolved in 42 microliter Universal Hybridization Solution (Corning) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed using the Pronto Plus System (Promega)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0349_2_Hv3_35k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL5186","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497966/GSM497966.gpr.gz","20866"
"GSM497967","UC_0372_1_Hv3_35k_h1","GSM497967","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0372_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: T3","tumor grade: G3","dead of disease: NO","follow up time (months): 29.9","cystectomy: YES","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Samples were dissolved in 42 microliter Universal Hybridization Solution (Corning) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed using the Pronto Plus System (Promega)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0372_1_Hv3_35k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL5186","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497967/GSM497967.gpr.gz","20866"
"GSM497968","UC_0376_1_Hv3_35k_h1","GSM497968","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0376_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: T1","tumor grade: G3","dead of disease: NO","follow up time (months): 29.9","tat1 progress^to minv/cystectomy/dead: NO","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Samples were dissolved in 42 microliter Universal Hybridization Solution (Corning) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed using the Pronto Plus System (Promega)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0376_1_Hv3_35k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL5186","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497968/GSM497968.gpr.gz","20866"
"GSM497969","UC_0394_1_Hv3_35k_h1","GSM497969","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0394_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: T3","tumor grade: G3","dead of disease: YES","follow up time (months): 6.4","cystectomy: YES","distant metastasis: M+","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Samples were dissolved in 42 microliter Universal Hybridization Solution (Corning) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed using the Pronto Plus System (Promega)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0394_1_Hv3_35k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL5186","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497969/GSM497969.gpr.gz","20866"
"GSM497970","UC_0399_1_Hv3_35k_h1","GSM497970","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0399_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: T2","tumor grade: G3","dead of disease: NO","follow up time (months): 26.7","cystectomy: YES","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Samples were dissolved in 42 microliter Universal Hybridization Solution (Corning) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed using the Pronto Plus System (Promega)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0399_1_Hv3_35k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL5186","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497970/GSM497970.gpr.gz","20866"
"GSM497971","UC_0410_1b_Hv3_35k_h2","GSM497971","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0410_1b","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: T2","tumor grade: G3","","","","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Samples were dissolved in 42 microliter Universal Hybridization Solution (Corning) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed using the Pronto Plus System (Promega)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0410_1b_Hv3_35k_h2","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL5186","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497971/GSM497971.gpr.gz","20866"
"GSM497972","UC_0442_1_Hv3_35k_h1","GSM497972","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0442_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: T1","tumor grade: G3","dead of disease: NO","follow up time (months): 26.3","tat1 progress^to minv/cystectomy/dead: YES","cystectomy: YES","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Samples were dissolved in 42 microliter Universal Hybridization Solution (Corning) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed using the Pronto Plus System (Promega)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0442_1_Hv3_35k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL5186","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497972/GSM497972.gpr.gz","20866"
"GSM497973","UC_0455_1_Hv3_35k_h1","GSM497973","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0455_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: T3","tumor grade: G3","dead of disease: NO","follow up time (months): 24.9","cystectomy: YES","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Samples were dissolved in 42 microliter Universal Hybridization Solution (Corning) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed using the Pronto Plus System (Promega)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0455_1_Hv3_35k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL5186","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497973/GSM497973.gpr.gz","20866"
"GSM497974","UC_0458_1_Hv3_35k_h1","GSM497974","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0458_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: T2","tumor grade: G3","dead of disease: NO","follow up time (months): 30.6","cystectomy: YES","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Samples were dissolved in 42 microliter Universal Hybridization Solution (Corning) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed using the Pronto Plus System (Promega)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0458_1_Hv3_35k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL5186","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497974/GSM497974.gpr.gz","20866"
"GSM497975","UC_0466_1a_Hv3_35k_h1","GSM497975","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0466_1a","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: T3","tumor grade: G3","","","","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","Labeling of 5 micrograms of sample RNA was performed using the Pronto Plus System (Promega)","9606","Samples were dissolved in 42 microliter Universal Hybridization Solution (Corning) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed using the Pronto Plus System (Promega)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0466_1a_Hv3_35k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL5186","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497975/GSM497975.gpr.gz","20866"
